Recombinant Human ERCC5 Protein，His

ERCC5, also known as Excision Repair Cross-Complementation Group 5, is a crucial enzyme involved in the nucleotide excision repair (NER) pathway, which plays a vital role in repairing bulky DNA adducts and various forms of DNA damage caused by environmental agents such as UV radiation and chemical carcinogens. Mutations in the ERCC5 gene are linked to xeroderma pigmentosum, a rare genetic disorder characterized by extreme sensitivity to sunlight and a predisposition to skin cancer. The study of ERCC5 recombinant proteins is essential for elucidating the mechanisms of NER and understanding its role in maintaining genomic stability. By producing and characterizing ERCC5 recombinant proteins, researchers aim to investigate their enzymatic activity, binding properties, and interactions with other proteins involved in the DNA repair process. This research not only enhances our understanding of DNA repair mechanisms but also has potential implications for developing targeted therapies for diseases associated with DNA repair deficiencies, including cancer. Furthermore, the investigation of ERCC5 may lead to advancements in gene therapy approaches and improve our knowledge of the molecular foundations underlying skin cancer susceptibility. Overall, the exploration of ERCC5 recombinant proteins represents a significant area of research that bridges molecular biology and clinical applications, offering insights that could lead to innovative strategies for disease prevention and treatment.